Spots Global Cancer Trial Database for A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple Myeloma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Participants With Relapsed or Refractory Multiple Myeloma
Official Title: A Randomized, Multicenter, Open-label, Phase 3 Study to Compare Daratumumab, Bortezomib, and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Chinese Subjects With Relapsed or Refractory Multiple Myeloma
Study ID: NCT03234972
Conditions
Study Description
Brief Summary: The primary purpose of this study is to compare the efficacy of daratumumab when combined with Velcade (bortezomib) and dexamethasone (DVd) to that of Velcade and dexamethasone (Vd), in terms of progression free survival (PFS) in Chinese participants with relapsed or refractory multiple myeloma (MM).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Peking Union Medical College Hospital, Beijing, , China
Peking University First Hospital, Beijing, , China
Peking University People s Hospital, Beijing, , China
Peking University Third Hospital, Beijing, , China
The First Hospital of Jilin University, Changchun, , China
West China Hospital Si Chuan University, Chengdu, , China
Xinqiao Hospital of the Third Military Medical University, Chongqing, , China
Fujian Meidical University Union Hospital, Fuzhou, , China
Guangdong Provincial People's Hospital, Guangzhou, , China
The First Affiliated Hospital Sun Yat sen University, Guangzhou, , China
Nanfang Hospital, Guangzhou, , China
First Affiliated Hospital Medical School of Zhejiang University, Hangzhou, , China
First affiliated Hospital of Zhejiang University, Hangzhou, , China
Nanjing Drum Tower Hospital, Nanjing, , China
Zhongda Hospital Southeast University, Nanjing, , China
Jiangsu Province Hospital, Nanjing, , China
Shanghai Changzheng Hospital, Shanghai, , China
Ruijin Hospital Shanghai Jiao Tong University, Shanghai, , China
First Affiliated Hospital SooChow University, Suzhou, , China
Tianjin cancer hospital, Tianjin, , China
Tianjin Medical University General Hospital, Tianjin, , China
Institute of Hematology and Blood Diseases Hospital, Tianjin, , China
Tongji Hospital, Tongji Medical College of HUST, Wuhan, , China
Tangdu Hospital, Xian, , China
Henan Cancer Hospital, Zhengzhou, , China
National Taiwan University Hospital, Taipei, , Taiwan
Tri-Service General Hospital, Taipei, , Taiwan
Contact Details
Name: Janssen Research & Development, LLC Clinical Trial
Affiliation: Janssen Research & Development, LLC
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
